相关实验视频

Updated: Jan 9, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

脂蛋白 (a) - 在发育过程中的治疗方法

Brian Tomlinson¹, Chak Fun Law¹

¹Faculty of Medicine, Macau University of Science & Technology, Macau, China.

Expert opinion on pharmacotherapy

|December 6, 2025

概括

像佩拉卡森和siRNA药物等新型疗法显著降低脂蛋白[Lp[a],这是一个关键的心血管风险因素. 目前正在进行的试验将确定降低Lp (a) 水平的临床益处.

科学领域:

心血管医学心血管医学
药理学药理学是指药理学的学科.
遗传学遗传学是一个

背景情况:

脂蛋白 (Lp) 是心血管疾病的独立风险因素,包括动脉瘤性心血管疾病和大动脉狭窄症.
目前的降脂药对升高的Lp(a) 水平的影响很小,需要新的治疗策略.

研究的目的:

审查正在开发的新疗法,以降低升高的Lp (a) 水平.
专注于临床开发先进阶段的药物.

主要方法:

在PubMed的搜索中,寻找新的降低Lp (a) 的疗法.
对处于先进开发阶段的药物进行审查,包括反意义寡核酸 (ASO),小干扰RNA (siRNA) 和小分子.

主要成果:

结合N-乙银胺 (GalNAc) 的ASO皮拉卡森和siRNA剂 (olpasiran,lepodisiran,zerlasiran) 显示出高的安全性和有效性,降低了Lp(a的80-100%.
口服小分子穆瓦拉普林显示高达65%的Lp (a) 减少.
佩拉卡森,奥尔帕西兰和莱波迪西兰正在进行心血管结果研究的第三阶段,预计结果将在2026年公布. 穆瓦拉普林也正在接受心血管结果评估.

结论:

几种新型疗法显示出降低Lp (a) 的显著潜力,并可能为心血管提供好处.
进一步的研究至关重要,以确定最佳的基线Lp(a) 水平和临床益处的目标降低百分比,并评估积极的Lp(a) 降低的潜在不良影响.

关键词:

佩拉卡森 (Pelacarsen) 是一个鱼.莱波迪斯兰 (Lepodisiran) 是一个穆瓦拉普林是什么意思奥尔帕西兰人 (Olpasiran) 是一个古老的民族.泽拉西兰是什么意思

更多相关视频

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

相关概念视频

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

Lipid-derived Compounds in the Human Body

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...

Overview of Lipid Metabolism

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...